(2E)-1-{[1,1'-biphenyl]-4-yl}-3-(2,3-dimethoxyphenyl)prop-2-en-1-one, 95.0%, 2g

Ethyl 3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)propanoate, 95%, 5g

(S)-5-Benzyl-2-(2,4,6-trichlorophenyl)-5,6-dihydro-8H-[1,2,4]triazolo[3,4-c][1,4]oxazin-2-ium tetrafluoroborate, 98%, 250mg

(R,S)-LeuP(OPh)2�HCl, 98.0%, 250mg

N2-(tert-butoxycarbonyl)-N6-(5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanoyl)-L-lysine, 97%, 5g

benzyl 3-{[(4-fluorophenyl)amino]carbonyl}piperidine-1-carboxylate, 1g

6-Phenyl-3(2H)-pyridazinone>98.0%(GC)1g

1,3,4,6-TETRA-O-ACETYL-2-DEOXY-2-PHTHALIMIDO-BETA-D-GLUCOPYRANOSE, 95%, 25g

[1,1':3',1''-Terphenyl]-4,4''-dicarboxylic acid, 5'-(4-carboxyphenyl)-2'-methyl-, 98%, 100mg

(2-Fluoro-6-(trifluoromethyl)phenyl)methanamine hydrochloride, 95.0%, 10g

(2-Cyclopropylthiazol-4-yl)methanol, 97%, 100mg

N,N-Dimetilformamida (DMF), 1 l

2-(4-Hydroxyphenoxy)propanoic acid, 95.0%, 5g